The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)
Showing 1-7 of 7 articles
Optical coherence tomography findings: insights from the “randomised multicentre trial investigating angiographic outcomes of hybrid sirolimus-eluting stents with biodegradable polymer compared with everolimus-eluting stents with durable polymer in chronic total occlusions” (PRISON IV) trial
Teeuwen K,
Spoormans E,
Bennett J,
Dubois C,
Desmet W,
Ughi G,
Belmans A,
Kelder J,
Tijssen J,
Agostoni P,
Suttorp MJ,
Adriaenssens T
August 4, 2017 | 10.4244/EIJ-D-17-00261
Automated characterisation of lipid core plaques in vivo by quantitative optical coherence tomography tissue type imaging
Gnanadesigan M,
Kameyama T,
Karanasos A,
van Ditzhuijzen N,
van der Sijde J,
van Geuns R,
Ligthart J,
Witberg K,
Ughi G,
van der Steen A,
Regar E,
van Soest G
December 20, 2016 | 10.4244/EIJ-D-15-00320
COmplex coronary Bifurcation lesions: RAndomized comparison of a strategy using a dedicated self-expanding biolimus-eluting stent versus a culotte strategy using everolimus-eluting stents: primary results of the COBRA trial
Dubois C,
Bennett J,
Dens J,
De Cock D,
Desmet W,
Belmans A,
Ughi G,
Sinnaeve P,
Vrolix M,
D’hooge J,
Adriaenssens T
April 20, 2016 | 10.4244/EIJY15M05_02
STACCATO (Assessment of Stent sTrut Apposition and Coverage in Coronary ArTeries with Optical coherence tomography in patients with STEMI, NSTEMI and stable/unstable angina undergoing everolimus vs. biolimus A9-eluting stent implantation): a randomised controlled trial
Adriaenssens T,
Ughi G,
Dubois C,
De Cock D,
Onsea K,
Bennett J,
Wiyono S,
Sinnaeve P,
Coosemans M,
Ferdinande B,
Belmans A,
D’hooge J,
Desmet W
April 8, 2016 | 10.4244/EIJV11I14A313
Optical coherence tomography-based assessment of bifurcation stenting using the Axxess™ Biolimus A9™-eluting stent system
January 20, 2016 | 10.4244/EIJV11I9A208
Optical coherence tomography study of healing characteristics of paclitaxel-eluting balloons vs. everolimus-eluting stents for in-stent restenosis: the SEDUCE (Safety and Efficacy of a Drug elUting balloon in Coronary artery rEstenosis) randomised clinical trial
Adriaenssens T,
Dens J,
Ughi G,
Bennett J,
Dubois C,
Sinnaeve P,
Wiyono S,
Coosemans M,
Belmans A,
D’hooge J,
Vrolix M,
Desmet W
August 19, 2014 | 10.4244/EIJV10I4A77
Latest news
NEW ISSUE
Part 2 of the consensus document of the European Bifurcation Club; one-month DAPT after PCI depending on clinical presentation; ARC high bleeding risk criteria and TAVI; and more
August 19, 2022
AHEAD OF PRINT
Ticagrelor monotherapy in PCI patients with prior CABG: the TWILIGHT-CABG study
FREE ARTICLE - Gennaro Sardella et al
August 18, 2022
AHEAD OF PRINT
First-in-human implantation of the Topaz transcatheter tricuspid valve replacement system
FREE ARTICLE - Emmanuel Teiger et al
August 16, 2022
AHEAD OF PRINT
Extracardiac basal annuloplasty for the treatment of secondary mitral regurgitation
FREE ARTICLE - Jérémy Bernard et al
August 11, 2022
AHEAD OF PRINT
LVOT calcification in TAVI : a post hoc analysis from the SOLVE-TAVI trial
FREE ARTICLE - Serdar Farhan et al
August 9, 2022
AHEAD OF PRINT
RADIANCE-HTN SOLO 36-month analysis
FREE ARTICLE - Florian Rader et al
August 1, 2022
AHEAD OF PRINT
Percutaneous left atrial appendage closure with superior vascular access
FREE ARTICLE - Roberto Galea et al
August 4, 2022